Pfizer, FDA in talks on prescription details for key breast cancer drug

January 8, 2015 4:22 PM

4 0

Pfizer, FDA in talks on prescription details for key breast cancer drug

(Reuters) - Pfizer Inc said Thursday it has begun talks with the U.S. Food and Drug Administration to finalize the prescription label of its breast cancer drug palbociclib, in an indication the drug was likely closer to regulatory approval.

The largest U.S. drugmaker also said there was no plan for the agency to hold an advisory committee meeting to discuss the medicine prior to an approval decision.

Also read: UPDATE 1-Industrial equipment hire firm Ashtead hikes annual results forecast

Read more

To category page

Loading...